Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares Issued
Ratios

Zevra Therapeutics (ZVRA) Long-Term Debt Issuances (2016 - 2024)

Historic Long-Term Debt Issuances for Zevra Therapeutics (ZVRA) over the last 4 years, with Q2 2024 value amounting to $59.0 million.

  • Zevra Therapeutics' Long-Term Debt Issuances rose 5184561.4% to $59.0 million in Q2 2024 from the same period last year, while for Sep 2025 it was $59.0 million, marking a year-over-year decrease of 579.69%. This contributed to the annual value of $59.0 million for FY2024, which is 3902.57% up from last year.
  • According to the latest figures from Q2 2024, Zevra Therapeutics' Long-Term Debt Issuances is $59.0 million, which was up 5184561.4% from $3.6 million recorded in Q4 2023.
  • Over the past 5 years, Zevra Therapeutics' Long-Term Debt Issuances peaked at $59.0 million during Q2 2024, and registered a low of -$114000.0 during Q2 2023.
  • Moreover, its 3-year median value for Long-Term Debt Issuances was $12.9 million (2022), whereas its average is $19.0 million.
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first crashed by 10089.06% in 2023, then soared by 5184561.4% in 2024.
  • Over the past 3 years, Zevra Therapeutics' Long-Term Debt Issuances (Quarter) stood at $12.8 million in 2022, then crashed by 71.64% to $3.6 million in 2023, then soared by 1525.07% to $59.0 million in 2024.
  • Its Long-Term Debt Issuances was $59.0 million in Q2 2024, compared to $3.6 million in Q4 2023 and $26.0 million in Q3 2023.